Table 1.

Medications Used in the Treatment of Attention-Deficit/Hyperactivity Disorder

Generic Class (Brand Name)Daily Dosage ScheduleDurationPrescribing Schedule
Stimulants (First-Line Treatment)
 Methylphenidate
  Short-acting
(Ritalin, Metadate, Methylin)
Twice a day (BID) to 3 times a day (TID)3–5 hr5–20 mg BID to TID
  Intermediate-acting
(Ritalin SR, Metadate ER, Methylin ER)
Once a day (QD) to BID3–8 hr20–40 mg QD or 40 mg in the morning and 20 early afternoon
  Extended Release
(Concerta, Metadate CD, Ritalin LA*)
QD8–12 hr18–72 mg QD
 Amphetamine
  Short-acting
(Dexedrine, Dextrostat)
BID to TID4–6 hr5–15 mg BID or 5–10 mg TID
  Intermediate-acting
(Adderall, Dexedrine spansule)
QD to BID6–8 hr5–30 mg QD or 5–15 mg BID
  Extended Release
(Adderall-XR*)
QD10–30 mg QD
Antidepressants (Second-Line Treatment)
 Tricyclics (TCAs)BID to TID2–5 mg/kg/day
  Imipramine, Desipramine
 Bupropion
(Wellbutrin)
(Wellbutrin SR)
QD to TID
BID
50–100 mg TID
100–150 mg BID
  • *  Not FDA approved at time of publication.

  •  Prescribing and monitoring information inPhysicians' Desk Reference.